JP
PFE icon

John Paulson’s Pfizer PFE Stock Holding History

John Paulson’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-429,505
Closed -$13.9M – 116
2017
Q1 		$13.9M Buy
429,505
+58,286
+16% +$1.84M 0.19% 50
2016
Q4 		$11.4M Buy
371,219
+105,611
+40% +$3.22M 0.14% 62
2016
Q3 		$8.54M Sell
265,608
-272,354
-51% -$9.11M 0.09% 62
2016
Q2 		$18M Sell
537,962
-914,555
-63% -$29.2M 0.18% 45
2016
Q1 		$40.8M Buy
1,452,517
+785,651
+118% +$22.4M 0.3% 42
2015
Q4 		$20.4M Buy
+666,866
New +$21M 0.12% 44

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

John Paulson's PFE Position: Q2 2017 in Review

John Paulson sold out of Pfizer (PFE) in Q2 2017, closing a stake of 429,505 shares — an estimated $13.9M sold.

John Paulson first reported a position in PFE in Q4 2015 and held it in 6 quarters. The position peaked at $40.8M in Q1 2016. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

  • John Paulson reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
  • John Paulson sold 429,505 Pfizer shares in Q2 2017, an estimated $13.9M.
  • John Paulson first reported a position in Pfizer in Q4 2015 and held it in 6 quarters.
  • John Paulson's Pfizer position peaked at $40.8M in Q1 2016.
  • 2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Paulson & Co's 13F filing for Q2 2017, filed 14 Aug 2017.